twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2005
vol. 107
 
Share:
Share:
abstract:
Review paper

The pre­sent ro­le of pro­sta­glan­din ana­lo­gu­es in the me­di­cal tre­at­ment of glau­co­ma

Jo­an­na Wierz­bow­ska
1
,
Marek Rękas
1
,
Da­ria Ma­law­ko
1

  1. Klinika Okulistyki Wojskowego Instytutu Medycznego w Warszawie
Klinika Oczna 2005, 107(4-6): 312-315
Online publish date: 2005/07/02
View full text Get citation
 
Therapy with prostaglandin analogues (PGA), a novel class of intraocular-lowering medications, represents a safe and very effective pharmacologic method of treating patients with glaucoma and ocular hypertension. The convince dosing regimen, once-daily, higher efficacy and higher systemic safety profile seen with PGA compared with betablockers caused that these agents have been approved by regulatory bodies for both the first-line and adjunctive therapy. Short, retrospective analysis of the medical treatment of glaucoma in the Ophthalmology Clinic of Military Health Service Institute in Warsaw, in 2003-2004, was presented.
keywords:

the medical treatment of glaucoma, the first-line therapy, the adjunctive therapy, prostaglandin analogues, safety profile of the treatment

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.